Hassing CMS, Mejdahl MK, Laenkholm AV, Kroman N, et al. Benefit of adjuvant chemotherapy and trastuzumab in patients with HER2-positive,
node-negative breast tumors = 10 mm: a nationwide study. Breast Cancer Res Treat 2022;196:197-206.
PMID: 36076126